Royal Dutch Pharmacists Association

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Cathelijne H. van der Wouden, Anne Cambon‐Thomsen, Erika Cecchin et al. · Clinical Pharmacology & Therapeutics · 2016 · 288 citations · Full text

Relevant Pgx-markers, Genetic Epidemiology, Ubiquitous Pharmacogenomics +22

Mutations at Amino Acid Position 315 of the<i>katG</i>Gene Are Associated with High‐Level Resistance to Isoniazid, Other Drug Resistance, and Successful Transmission of<i>Mycobacterium tuberculosis</i>in The Netherlands

Dick van Soolingen, Petra E. W. de Haas, H. Rogier van Doorn et al. · The Journal of Infectious Diseases · 2000 · 226 citations · Full text

Mycobacterium Tuberculosis Isolates, Genetics, Tuberculosis Prevention +20

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines

Carin A.T.C. Lunenburg, Cathelijne H. van der Wouden, Marga Nijenhuis et al. · European Journal of Human Genetics · 2019 · 218 citations · Full text

Independent component approach to the analysis of EEG recordings at early stages of depressive disorders

Vera A. Grin-Yatsenko, Ineke Baas, Juri D. Kropotov · Clinical Neurophysiology · 2009 · 207 citations

Neuropsychology, Eeg Recordings, Affective Neuroscience +17